Alternative Data for CG Oncology
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 1 | Sign up | Sign up | Sign up |
| Sentiment | 75 | Sign up | Sign up | Sign up |
| Employee Rating | 30 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 8 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 498 | Sign up | Sign up | Sign up |
| X Followers | 446 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 100 | Sign up | Sign up | Sign up |
| Linkedin Employees | 176 | Sign up | Sign up | Sign up |
About CG Oncology
CG Oncology, Inc. (Nasdaq: CGON), is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative oncolytic immunotherapies to live with dignity and have an enhanced quality of life.
| Price | $55.10 |
| Target Price | Sign up |
| Volume | 882,320 |
| Market Cap | $4.45B |
| Year Range | $23.95 - $57.13 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Health Care Services |
In the news
 |
CG Oncology, Inc. (CGON) Presents at 44th Annual J.P. Morgan Healthcare Conference - SlideshowJanuary 19 - SeekingAlpha |
Insider Transactions View All
Similar companies
Read more about CG Oncology (CGON) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, employee rating, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - CG Oncology
The Market Cap of CG Oncology is $4.45B.
Currently, the price of one share of CG Oncology stock is $55.10.
The CGON stock price chart above provides a comprehensive visual representation of CG Oncology's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling CG Oncology shares. Our platform offers an up-to-date CGON stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, CG Oncology (CGON) does not offer dividends to its shareholders. Investors interested in CG Oncology should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of CG Oncology are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.
